TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Drug regulator cracks down on illegal prescription skincare products

The Food and Drug Monitoring Agency (BPOM) is scaling up efforts to clamp down on the illicit trade of prescription skincare products amid growing concerns from the public about the impact on health.

Nina A. Loasana (The Jakarta Post)
Premium
Jakarta
Tue, October 15, 2024

Change text size

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Drug regulator cracks down on illegal prescription skincare products An illustration of skincare products (Shutterstock/File)

T

he Food and Drug Monitoring Agency (BPOM) is scaling up its efforts to clamp down on the illicit trade of prescription skincare products amid growing concerns from the public about the impact on health.

The BPOM temporarily closed down a factory in Bandung, West Java, over the weekend on suspicion of mass producing illegal prescription skincare.

Spokesperson for the drug regulator Eka Rosmalasari said the factory had “repeatedly and systemically violated” prevailing health regulations and that the incidents possibly affected the safety of their products.

"We have banned the factory from producing any products for the next 30 working days and have asked them to impose corrective actions,” Eka said over the weekend as reported by Kompas.com.

“We’re also investigating deeper into the factory operations to find possible criminal violations,” she added.

Unlike over-the-counter beauty products, prescription skincare is a personalized skin treatment typically containing strong, active ingredients such as tretinoin, hydroquinone or corticosteroids that must be prescribed by dermatologists to ensure the right dosage and minimize the risk of adverse side effects.

Morning Brief

Every Monday, Wednesday and Friday morning.

Delivered straight to your inbox three times weekly, this curated briefing provides a concise overview of the day's most important issues, covering a wide range of topics from politics to culture and society.

By registering, you agree with The Jakarta Post's

Thank You

for signing up our newsletter!

Please check your email for your newsletter subscription.

View More Newsletter

It is often referred to as “blue label” skincare because its prescription label is blue, just like any other prescription topical medication.

to Read Full Story

  • Unlimited access to our web and app content
  • e-Post daily digital newspaper
  • No advertisements, no interruptions
  • Privileged access to our events and programs
  • Subscription to our newsletters
or

Purchase access to this article for

We accept

TJP - Visa
TJP - Mastercard
TJP - GoPay

Redirecting you to payment page

Pay per article

Drug regulator cracks down on illegal prescription skincare products

Rp 29,000 / article

1
Create your free account
By proceeding, you consent to the revised Terms of Use, and Privacy Policy.
Already have an account?

2
  • Palmerat Barat No. 142-143
  • Central Jakarta
  • DKI Jakarta
  • Indonesia
  • 10270
  • +6283816779933
2
Total Rp 29,000

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.

Share options

Quickly share this news with your network—keep everyone informed with just a single click!

Change text size options

Customize your reading experience by adjusting the text size to small, medium, or large—find what’s most comfortable for you.

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!